Close

Anticoagulation Part 2 – Introduction and Refresher Training to use INRstar

December 1 2021

Written by

Following on from Part 1 of our anti coagulation training, Frimley Training Hub is delighted to be working with lumiradx to offer healthcare assistants, nurses, and allied health professionals the opportunity for an introduction or refresher training to use INRstar.

The training is delivered for INRstar Clinical users at 3 levels. Take a look at each of the the levels’ criteria below. 

Introduction or Refresher Clinical Level 1 training (suitable for HCA, Phlebotomists and pharmacy technicians)

A clinical level 1 INRstar user often has regular contact with patients and would manage stable patients with no changes to their treatments. Our Level 1 training is a practical and thorough clinical demonstration which covers how to:

  • Suspend patients’ treatment plan when appropriate
  • Accurately input INR results from external and internal testing locations
  • Understand other INRstar roles and permissions and their context
  • Maintain POCT test, IQC and EQC records
  • Recognise and understand the implications of an abnormal reading
  • Know what action should be taken and when to refer to a higher level of clinical support to manage the patient

Clinical Level 2 training (suitable for registered nurses and practice nurses)

A clinical level 2 user has all the permissions of a clinical level 1 user. Level 2 users should be qualified clinical professionals.

Clinical Level 3 training – Lead Clinical Nurse or GP

A clinical level 3 user has all the permissions of a Level 1 and 2 user. Level 3 users should be a GP, pharmacist or nurse prescriber aiming to, or have completed, an MSc level anticoagulation management training course.

Introduction or Refresher Clinical Level 2 and 3 training is combined and includes an overview of the system for users who make dose changes to a patient’s prescription and authorise referrals from users with a lower level of permission.

The training delivers a comprehensive overview of the system and covers the following INRstar functionality;

  • Add INR and treatment schedule
  • Recognise the implications of an abnormal reading, when to seek higher level of clinical support and what action to be taken to manage the patient
  • Complete out-of-range treatments without changing doses after referral to higher level clinical support
  • Override and/or management of patients who are out of range, missed dose, or started new treatments
  • Create a treatment plan, add diagnosis, treatment initiation to include induction/ maintenance/manual dosing management. Make changes to patients’ clinical details to include initiate and manage treatment plans
  • Add a non-warfarin patient – DOAC ( Direct Oral Anticoagulant) or Dalteparin
  • Conduct annual review for patients treated with warfarin or a newer, direct oral anticoagulant (NOAC/DOAC)
  • How to suspend, reactivate and inactivate patients
  • Perform and record quality control including POCT testing records, IQC and EQC
  • Record adverse events
  • Run reports – NPSA, TTR range, location reports relevant to quality and treatments

Expressions of interest has now closed